These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1758856

  • 41. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ, Bös M, Weber D, Winkler K, Hanfland P, Preusse CJ.
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [Abstract] [Full Text] [Related]

  • 42. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS, Levy JH, van Aken H, Feneck RO, Latimer RD, Ott E, Martin E, Birnbaum DE, Bonfiglio LJ, Kajdasz DK, Despotis GJ.
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [Abstract] [Full Text] [Related]

  • 43. [Biochemical mechanisms of thoracic fibrosis development after pneumonectomy in patients operated for progressive pulmonary tuberculosis].
    Kaminskaia GO, Grigor'eva EV, Testov VV.
    Probl Tuberk; 1999 Jul; (1):51-4. PubMed ID: 10199187
    [Abstract] [Full Text] [Related]

  • 44. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
    Wang Y, Liu Y, Han R, Zhu Z, Zhang Y, Wang X, Wang L, Shen Z.
    Thromb Res; 2008 Jul; 122(2):161-6. PubMed ID: 18048090
    [Abstract] [Full Text] [Related]

  • 45. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA, Neporada EL, Turundaevskaia OV, Mel'nikova GN.
    Anesteziol Reanimatol; 2007 Jul; (2):42-4. PubMed ID: 17563999
    [Abstract] [Full Text] [Related]

  • 46. Oxymetholone therapy in patients with familial antithrombin III deficiency.
    Shibuya A, Ninomiya H, Nakazawa M, Nagasawa T, Yoda Y, Abe T.
    Thromb Haemost; 1988 Dec 22; 60(3):495-7. PubMed ID: 3238652
    [Abstract] [Full Text] [Related]

  • 47. Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant woman with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markers.
    Inomoto T, Takamoto M, Tamura R, Maegawa M, Kamada M, Takayanagi M.
    Haemostasis; 1991 Dec 22; 21(3):147-54. PubMed ID: 1773985
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Antithrombin III concentrate. Thromboprophylaxis during pregnancy in a patient with congenital antithrombin III deficiency.
    Tengborn L, Bengtsson T.
    Acta Obstet Gynecol Scand; 1986 Dec 22; 65(4):375-6. PubMed ID: 3739652
    [No Abstract] [Full Text] [Related]

  • 51. [Evaluation of preoperative hemostasis: a change for continuity?].
    Bléry C.
    Ann Fr Anesth Reanim; 2001 Oct 22; 20(8):669-71. PubMed ID: 11695284
    [No Abstract] [Full Text] [Related]

  • 52. Hemostatic changes in active pulmonary tuberculosis.
    Turken O, Kunter E, Sezer M, Solmazgul E, Cerrahoglu K, Bozkanat E, Ozturk A, Ilvan A.
    Int J Tuberc Lung Dis; 2002 Oct 22; 6(10):927-32. PubMed ID: 12365581
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [The preoperative preparation and surgical treatment of patients with progressive extensive destructive pulmonary tuberculosis].
    Prystaĭko IaI.
    Klin Khir; 1995 Oct 22; (3):33-6. PubMed ID: 9053225
    [No Abstract] [Full Text] [Related]

  • 55. [Effect of proteolytic and antiproteolytic blood system on hemocoagulation in phthisiosurgical patients].
    Bogush LK, Kaminskaia GO, Serebrianaia BA, Shipeneva NM.
    Grudn Khir; 1977 Oct 22; (1):39-43. PubMed ID: 838384
    [No Abstract] [Full Text] [Related]

  • 56. [The evaluation of the measurement of serum fibronectin in pulmonary tuberculosis].
    Cioflec D, Ion N, Tudorache V, Hudiţeanu O, Chira Z, Luţă V, Neagoe D, Sfetcu V, Stoienescu D, Jemna I.
    Rev Ig Med Muncii Med Soc Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1990 Oct 22; 39(2):149-55. PubMed ID: 2131813
    [Abstract] [Full Text] [Related]

  • 57. [Pathogenesis of anemia in patients with fibrous-cavernous pulmonary tuberculosis].
    Zinov'ev IP, Druzhinina GE, Diveeva LM.
    Probl Tuberk; 1978 Jan 22; (1):51-5. PubMed ID: 634962
    [No Abstract] [Full Text] [Related]

  • 58. [The characteristic of the initial hemostatic status of patients requiring surgical treatment for lung diseases].
    Kalabukha IA.
    Lik Sprava; 1999 Jun 22; (4):75-7. PubMed ID: 10476649
    [Abstract] [Full Text] [Related]

  • 59. [The dynamics of the intoxication indices during the performance of the preoperative preparation of patients with disseminated progressive destructive pulmonary tuberculosis].
    Prystaĭko IaI.
    Klin Khir; 1995 Jun 22; (6):11-3. PubMed ID: 8673871
    [No Abstract] [Full Text] [Related]

  • 60. Unveiling the new face of fibronectin in thrombosis and hemostasis.
    Ni H.
    J Thromb Haemost; 2006 May 22; 4(5):940-2. PubMed ID: 16689738
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.